Sunresin New Materials Co (300487) Q3 2025 earnings summary

Executive summary

• Revenue for the first nine months reached ¥1.93 billion, up 2.20% year-over-year, with Q3 revenue at ¥685.98 million, a 14.86% increase compared to the same quarter last year.

• Net profit attributable to shareholders for the first nine months was ¥651.73 million, up 9.27% year-over-year; Q3 net profit was ¥207.20 million, up 7.72% year-over-year.

• The company is investing in a new high-end life sciences materials industrial park with a planned investment of ¥1.15 billion to support rapid business growth.

Financial highlights

• Operating cash flow for the first nine months was ¥538.85 million, up 20.50% year-over-year.

• Basic EPS for the first nine months was ¥1.29, up 9.32% year-over-year; Q3 EPS was ¥0.41, up 7.89% year-over-year.

• Total assets at period end were ¥6.41 billion, up 5.41% from the previous year-end.

• Shareholders’ equity attributable to listed company shareholders was ¥4.18 billion, up 6.87% from year-end.

• Non-recurring profit and loss for the first nine months totaled ¥12.42 million, mainly from government subsidies and fair value changes.

Outlook and guidance

• The new life sciences materials park is expected to meet growing order demand and enhance product standards, aligning with strategic growth plans.